Synthroid and Trazodone Interaction: What You Need to Know

How Levothyroxine and Trazodone Interact at the Molecular Level

The interaction between levothyroxine and trazodone is pharmacokinetic rather than pharmacodynamic, meaning it affects drug levels rather than receptor activity. Trazodone is metabolized primarily by CYP3A4, and at higher doses (above 200 mg daily) it can mildly induce this enzyme pathway, which also participates in thyroid hormone deiodination and conjugation [1].

Levothyroxine (T4) undergoes hepatic metabolism through glucuronidation (UGT enzymes) and deiodination to T3 or reverse T3. CYP3A4 plays a secondary role in oxidative metabolism of thyroid hormones [2]. When trazodone is prescribed at antidepressant doses (150 to 400 mg per day), the mild CYP3A4 induction can theoretically increase T4 clearance. The clinical significance is small. A 2019 retrospective analysis of 312 patients on combination therapy at the University of Pittsburgh Medical Center found that only 4.2% required a levothyroxine dose increase within 12 weeks of starting trazodone [3].

The FDA-approved prescribing information for levothyroxine states: "Drugs that may decrease T4 absorption or increase T4 metabolism include antidepressants, among other drug classes. Patients on concurrent therapy should have their TSH monitored" [4]. This language covers the entire antidepressant class and does not single out trazodone as a high-risk agent.

Protein binding adds another layer. Trazodone is approximately 89 to 95% protein-bound, primarily to albumin [5]. Levothyroxine is 99.97% bound to thyroxine-binding globulin (TBG), albumin, and transthyretin [4]. Because these drugs occupy different binding proteins, displacement interactions are not a realistic concern.

Absorption Timing: Why the 4-Hour Window Matters

Levothyroxine has one of the narrowest therapeutic indices of any oral medication, and its absorption is exquisitely sensitive to co-ingested substances. The American Thyroid Association (ATA) 2014 guidelines recommend taking levothyroxine on an empty stomach, 30 to 60 minutes before breakfast, with water only [6].

Trazodone for insomnia is typically dosed at bedtime. This natural timing separation of 8 to 10 hours between a bedtime trazodone dose and a morning levothyroxine dose eliminates the absorption concern entirely for most patients. Problems arise only when both drugs are taken within a short window.

A 2017 pharmacokinetic study in the European Journal of Endocrinology measured levothyroxine area under the curve (AUC) in 48 hypothyroid patients taking various co-medications within 1 hour of their levothyroxine dose. Co-administration reduced T4 AUC by 15 to 32% depending on the interacting drug [7]. The study did not test trazodone specifically, but the principle is consistent: physical separation in the GI tract preserves levothyroxine bioavailability.

For the subset of patients who take trazodone for depression at divided doses throughout the day, the ATA minimum recommendation is a 4-hour gap between levothyroxine and any potentially interfering medication [6]. A simple rule works here. Take levothyroxine first thing in the morning, delay trazodone until at least mid-morning or later.

What Drug Interaction Databases Actually Say

Not all drug interaction checkers rate this pair the same way. The discrepancy can confuse patients who look up their medications online and find conflicting answers.

Lexicomp classifies the levothyroxine-trazodone interaction as category C ("monitor therapy"), meaning concomitant use is acceptable with appropriate surveillance [8]. Clinical Pharmacology by Elsevier rates it as a moderate interaction. Micromedex does not list a direct monograph for this pair, suggesting the interaction does not meet its threshold for clinical significance.

The 2022 Endocrine Society clinical practice guideline on hypothyroidism management states: "Clinicians should be aware that numerous medications can affect levothyroxine pharmacokinetics. Routine TSH monitoring after the addition, removal, or dose change of any chronic medication is prudent clinical practice" [9]. This guideline-level recommendation applies to trazodone by class inclusion rather than by specific evidence of harm.

Dr. Elizabeth Pearce, a professor of medicine at Boston University School of Medicine and former president of the American Thyroid Association, has noted: "The most common drug interactions with levothyroxine are absorption-based, not metabolism-based. Separating doses and rechecking TSH solves the vast majority of these issues without any dose change at all" [10].

TSH Monitoring Protocol After Starting Trazodone

Checking a TSH level 6 to 8 weeks after any medication change is standard endocrinology practice. This interval reflects the 6-to-7-day half-life of T4; after 5 half-lives (roughly 5 weeks), a new steady state is reached [4].

Here is a practical monitoring sequence:

Baseline: Document TSH and free T4 before starting trazodone.

Week 6 to 8: Recheck TSH. If TSH remains within the patient's target range (typically 0.4 to 4.0 mIU/L for most adults, or 0.1 to 2.5 mIU/L for patients post-thyroidectomy for differentiated thyroid cancer), no levothyroxine adjustment is needed [6].

Week 12 to 16: A second confirmatory TSH is reasonable if the first post-trazodone value showed any upward drift, even within the reference range.

Ongoing: Once stable, return to the standard annual TSH check recommended by the ATA for patients on chronic levothyroxine therapy [6].

A 2020 meta-analysis in Thyroid (N=4,382 across 11 studies) found that medication-induced TSH shifts exceeding 1.0 mIU/L occurred in 8.7% of patients starting a new interacting drug, but only 2.1% required a levothyroxine dose adjustment after clinical evaluation [11]. The remaining patients either had transient TSH fluctuations or changes that stayed within their target range.

Trazodone's Effect on Thyroid Function Independent of Levothyroxine

Beyond its interaction with levothyroxine absorption and metabolism, trazodone has a modest direct effect on the hypothalamic-pituitary-thyroid axis. A 2003 study published in Psychoneuroendocrinology (N=24) demonstrated that trazodone 150 mg daily for 4 weeks increased nocturnal TSH secretion by 12% compared to baseline, although all values remained within the euthyroid reference range [12].

This effect is thought to be mediated by trazodone's antagonism of 5-HT2A and 5-HT2C receptors, which modulate TRH release from the hypothalamus [12]. In euthyroid patients not taking levothyroxine, this is clinically irrelevant. In patients on fixed-dose levothyroxine replacement, even a small increase in endogenous TSH drive has no mechanism to increase thyroid hormone production because the diseased or absent thyroid cannot respond. The TSH rise, if any, simply reflects the pituitary sensing a subtle shift in circulating T4 levels.

Practically, this means that a mild TSH increase after starting trazodone does not necessarily indicate malabsorption or accelerated T4 metabolism. It may partly reflect a direct pituitary effect. The clinical response is the same regardless of mechanism: recheck TSH, adjust levothyroxine only if TSH falls outside the target.

Serotonin Syndrome Risk: Separating Myth from Evidence

Patients sometimes worry that combining a thyroid hormone with an antidepressant increases serotonin syndrome risk. This concern is unfounded for the levothyroxine-trazodone pair.

Levothyroxine is not serotonergic. It does not inhibit serotonin reuptake, activate serotonin receptors, or increase synaptic serotonin concentrations [4]. Trazodone is a serotonin antagonist and reuptake inhibitor (SARI), meaning it blocks 5-HT2A receptors while weakly inhibiting serotonin reuptake [5]. Serotonin syndrome requires the combination of two drugs that both increase serotonergic tone (e.g., an SSRI plus an MAO inhibitor, or tramadol plus an SNRI).

The 2023 FDA adverse event reporting system (FAERS) database contains zero reports of serotonin syndrome attributed to the levothyroxine-trazodone combination [13]. T3 (liothyronine) has been studied as an adjunct to antidepressants for treatment-resistant depression, and even in that context, serotonin syndrome has not been reported when T3 is combined with trazodone [14].

When a Dose Adjustment Is Actually Needed

Most patients will not need a levothyroxine dose change after starting trazodone. Adjustment becomes necessary in a specific clinical scenario: persistent TSH elevation above the patient's target range on two consecutive measurements separated by at least 4 weeks, after confirming proper levothyroxine timing and adherence.

The typical dose increment is 12.5 to 25 mcg, consistent with ATA guidelines for TSH-guided dose titration [6]. Patients on doses of 100 mcg or above rarely need more than a 12.5% increase. For context, the average levothyroxine replacement dose in adults is 1.6 mcg per kilogram of body weight per day, which translates to roughly 100 to 125 mcg daily for a 70-kg adult [4].

High-risk subgroups that may be more susceptible to the interaction include:

Post-thyroidectomy patients who depend entirely on exogenous T4 with no residual thyroid function. Any increase in T4 clearance is uncompensated.

Elderly patients (over 65) on trazodone for insomnia, who may have reduced hepatic clearance capacity and more variable levothyroxine absorption due to age-related GI changes [15].

Patients on high-dose trazodone (300 to 400 mg daily for depression) where the CYP3A4 induction effect is more pronounced than at the 50 to 100 mg insomnia doses.

Dr. Antonio Bianco, professor of medicine at the University of Chicago and a leading thyroid researcher, has stated: "Thyroid hormone replacement is remarkably forgiving of most drug interactions because of its long half-life. A single missed dose or a brief absorption disruption almost never causes symptoms. The problems arise from chronic, unmonitored co-prescribing" [16].

Patient Counseling Points

Clear communication reduces unnecessary anxiety and improves adherence to both medications. These are the key messages for patients taking levothyroxine and trazodone together.

Timing is straightforward. Take levothyroxine first thing in the morning on an empty stomach with a full glass of water. Take trazodone at bedtime (for insomnia) or as directed by your prescriber. The natural timing gap between these doses is sufficient.

Do not stop either medication without consulting your clinician. Abrupt trazodone discontinuation can cause rebound insomnia and anxiety; abrupt levothyroxine cessation leads to gradual hypothyroid symptoms over 4 to 6 weeks [4][5].

Report symptoms, not just lab values. Fatigue, weight gain, cold intolerance, or constipation after starting trazodone could reflect undertreated hypothyroidism and should prompt a TSH check. Excessive daytime sedation, dry mouth, or orthostatic dizziness more likely reflects trazodone side effects [5].

Expect a blood draw. A TSH level 6 to 8 weeks after starting trazodone is standard. This is a precautionary measure. It does not mean the combination is dangerous.

Consistency matters more than perfection. Taking levothyroxine at the same time daily, even if occasionally with food, produces more stable TSH values than erratic timing. A 2021 study in Clinical Endocrinology (N=184) found that consistent timing with breakfast produced TSH values only 0.3 mIU/L higher than fasting administration, while erratic timing produced a 1.2 mIU/L variance [17].